1,014
Views
20
CrossRef citations to date
0
Altmetric
Reviews

Secondary malignancies in patients with multiple myeloma, Waldenström macroglobulinemia and monoclonal gammopathy of undetermined significance

&
Pages 773-780 | Received 11 Jun 2016, Accepted 17 Jul 2016, Published online: 22 Aug 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Iuliana Vaxman & Morie Gertz. (2020) Waldenstrom's macroglobulinemia in the era of immunotherapy. Leukemia & Lymphoma 61:6, pages 1292-1304.
Read now

Articles from other publishers (19)

Shreyas Kalantri, Inderpreet Singh, Long Yang & Khadega A. Abuelgasim. (2023) Relapsed Waldenstrom’s Macroglobulinemia and Therapy-Related Myelodysplastic Syndrome with Complex Cytogenetics: A Treatment Dilemma. Case Reports in Oncology, pages 360-365.
Crossref
Jinming Song, Hailing Zhang, Ning Dong, Xiaohui Zhang, Mohammad Hussaini, Akriti Jain, Lynn Moscinski, Ken Shain, Rachid Baz, Melissa Alsina, Taiga Nishihori & Ling Zhang. (2022) The Application of NextGen Sequencing in the Diagnosis of Myeloid Neoplasms in Myeloma Patients With Cytopenia. Clinical Lymphoma Myeloma and Leukemia 22:6, pages e414-e426.
Crossref
Xinting Hu, Hua Wang, Dai Yuan, Huiting Qu, Ying Li, Na Wang, Xianghua Wang, Xin Liu, Hongzhi Xu, Ya Zhang & Xin Wang. (2022) An Extended Prognostic Index of the ISSWM Score Based on Thyroid Complications in Waldenström Macroglobulinemia/Lymphoplasmacytoid Lymphoma. Frontiers in Oncology 12.
Crossref
Sabrin TahriTarek H. Mouhieddine, Robert Redd, Luisa LampeKatarina I. NilssonHabib El-Khoury, Nang Kham Su, Amin H. Nassar, Elio AdibGovind BindraSarah Abou Alaiwi, Lorenzo TrippaDavid P. Steensma, Jorge J. Castillo, Steven P. Treon, Irene M. GhobrialAdam S. Sperling. (2022) Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia. Blood Advances 6:7, pages 2230-2235.
Crossref
Christin B. DeStefano, Steven J. Gibson, Adam S. Sperling, Paul G. Richardson, Irene Ghobrial & Clifton C. Mo. (2022) The emerging importance and evolving understanding of clonal hematopoiesis in multiple myeloma. Seminars in Oncology 49:1, pages 19-26.
Crossref
Morie A. Gertz. (2021) Waldenström macroglobulinemia: 2021 update on diagnosis, risk stratification, and management. American Journal of Hematology 96:2, pages 258-269.
Crossref
A. S. Rosenberg, A. Brunson, J. Tuscano, B. A. Jonas, R. Hoeg, T. Wun & T. H. M. Keegan. (2021) Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients. Blood Cancer Journal 11:1.
Crossref
Nicole H. Dalal, Graça M. Dores, Rochelle E. Curtis, Martha S. Linet & Lindsay M. Morton. (2020) Cause‐specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000–2016. British Journal of Haematology 189:6, pages 1107-1118.
Crossref
Katie S. Gatwood, Myriam Labopin, Bipin N. Savani, Jürgen Finke, Gerard Socie, Dietrich Beelen, Ibrahim Yakoub-Agha, Patrice Chevallier, Arnold Ganser, Didier Blaise, Noel Milpied, Lioure Bruno, Audrey Mailhol, Mohamad Mohty & Arnon Nagler. (2019) Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT study. Bone Marrow Transplantation 55:1, pages 224-232.
Crossref
Ryan B. Sinit, Dick G. Hwang, Prakash Vishnu, Jess F. Peterson & David M. Aboulafia. (2019) B-cell acute lymphoblastic leukemia in an elderly man with plasma cell myeloma and long-term exposure to thalidomide and lenalidomide: a case report and literature review. BMC Cancer 19:1.
Crossref
Alia Mowery, Michael Conlin & Daniel Clayburgh. (2019) Risk of Head and Neck Cancer in Patients With Prior Hematologic Malignant Tumors. JAMA Otolaryngology–Head & Neck Surgery 145:12, pages 1121.
Crossref
Florentia Dimitriou, Joanna Mangana, Alessandra Curioni-Fontecedro, Markus Rechsteiner, Patrick Turko, Ralph P. Braun, Reinhard Dummer & Phil F. Cheng. (2019) Melanoma patients with additional primary cancers: a single-center retrospective analysis. Oncotarget 10:36, pages 3373-3384.
Crossref
Peter Barth, Jorge J. Castillo & Adam J. Olszewski. (2018) Outcomes of secondary solid tumor malignancies among patients with myeloma: A population‐based study. Cancer 125:4, pages 550-558.
Crossref
Morie A. Gertz. (2019) Waldenström macroglobulinemia: 2019 update on diagnosis, risk stratification, and management. American Journal of Hematology 94:2, pages 266-276.
Crossref
Tonglin Hu, Jianping Shen, Wenbin Liu & Zhiying Zheng. (2019) Multiple myeloma secondary to acute lymphoblastic leukemia. Medicine 98:1, pages e14018.
Crossref
Navkirti Mittal, Ruchi Gupta, Khaliqur Rahman, Tanvi Gupta & Soniya Nityanand. (2018) Co-existence of myeloid neoplasm and monoclonal gammopathy; case series and review of literature. Hematology/Oncology and Stem Cell Therapy 11:3, pages 183-186.
Crossref
Morie A. Gertz. (2018) Waldenström macroglobulinemia treatment algorithm 2018. Blood Cancer Journal 8:4.
Crossref
Sergio Pina-Oviedo, Roberto N. Miranda & L. Jeffrey Medeiros. (2018) Cancer Therapy-associated Lymphoproliferative Disorders. American Journal of Surgical Pathology 42:1, pages 116-129.
Crossref
Weon Sup Shin, Soon Ki Park, Peter Verwilst, Seyoung Koo, Joung Hae Lee, Sung-Gil Chi & Jong Seung Kim. (2017) Targeted combinational therapy inducing mitochondrial dysfunction. Chemical Communications 53:7, pages 1281-1284.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.